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6LOSSARY 
GLOSSARY 
Definition of Terms 
Age at first full-term pregnancy is defined as the age of the woman at the last 
date of her first pregnancy that extended into completed 28 weeks, regardless of 
the outcome of the pregnancy (Ng et al. r 1997). 
Age at menarche is defined as the chronological age when the woman first had 
menstruation. 
Age at menopause is defined as the chronological age when the woman 
developed amenorrhoea of at least 6 months duration prior to the date of 
interview (Ng et al., 1997). 
Alcohol drinker includes former and current regular alcohol drinker of at least a 
glass per week for a month in duration. 
x 
Breast self-examination refers to the systematic examination of one's own 
breasts by a woman who believes she to be healthy for the purpose of preventing 
disease or detecting asymptomatic disease. 
Body mass index is calculated by using the formula, "W/H2- where W is weight 
in kilogram and H is height in metres. 
Cases refer to all breast cancer patients in this study who fulfilled the selection 
criteria. 
Cigarette smoker includes former and current regular and occasional smokers 
of at least a month in duration. 
Controls refer to non-breast cancer patients in this study that fulfilled the 
selection criteria. 
Ever taken regular oral contraceptive, hormone replacement therapy, traditional 
herbal medication, vitamins or micronutrient supplements include those who ever 
took these preparations regularly for at least one month and include current and 
former users. 
First-degree relatives include the mother, sisters or daughters while distant 
relatives include those other than first-degree relatives like cousins, the 
xi 
grandmother, granddaughters, aunts or nieces who has had breast cancer. 
Family history denotes either first degree or distant relatives. 
Parity is the number of pregnancy of more than 28 weeks duration with outcome 
of a Single or multiple live births or stillbirths. 
Practising low fat diet intake includes subjects who deliberately limited high fat 
intake in their diet. 
Practising regular exercise is defined as having physical activity of at least for 
20 minutes 3 times per week. 
Risk factors are factors that increase a person's chance of getting breast 
cancer. 
Subjects refer to all partiCipants in this study (cases and controls). 
Traditional herbal medication includes the usage of crude plant-based 
products or roots or leaves to prevent or cure a disease or an ailment (Glisson et 
al.,2000). 
xii 
Abbreviations 
8MI Body Mass Index 
SSE Breast Self-Examination 
CBE Clinical Breast Examination 
95% CI 95% Confidence Interval 
CIS Carcinoma In-Situ 
em centimetre 
HKB Hospital Kota Bharu 
HRT Hormone Replacement Therapy 
HUSM Hospital Universiti Sains Malaysia 
kg kilogram 
m metre 
NS Non-sig nitieant 
OC Oral Contraceptives 
OR Odds Ratio 
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USA The United States of America 
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ABSTRACTS 
ABSTRAK 
KAJIAN PROFIL, FAKTOR RISIKO DAN PENGETAHUAN, SIKAP DAN 
AMALAN DI KALANGAN WANITA KANSER PAYUDARA 01 KELANTAN 
Kanser payudara adalah kanser wanita paling kerap di dunia dengan prevalens 
di Malaysia seramai 86.2 per 100,000 wanita pada 1996. Terdapat peningkatan 
kadar kematian disebabkan oleh kanser payudara di Malaysia dan 0.6 pada 
1983 kepada 1.8 per 100,000 penduduk pada 1992. Tujuan kajian adalah untuk 
mengenalpasti profil, faktor risiko dan membandingkan tahap pengetahuan, 
sikap dan ama'an mengenai kanser payudara di antara pesakit kanser payudara 
dan kawalan. Kajian kes kawalan di hospital telah dijalankan di Kelantan. 
Soalselidik piawai digunakan untuk menemuduga 147 pesakit kanser payudara 
yang disahkan melalui histologi. KumpuJan kawalan seramai 147 dipadankan 
dengan umur dan kumpulan etnik kes dikalangan bukan pengidap penyakit 
kanser, sakit puan, gangguan harmon atau endokrin. Faktor risiko dan jumlah 
markah dianalisa menggunakan "simple conditional logistic regression n dan ujian 
berpasang t. Model "multiple conditional logistic regression" kemudian digunakan 
untuk mengawal "confounders". Min umur pesakit kanser payudara adalah 46.3 + 
9.3 tahun. Jenis histologi paling kerap ialah "infiltrative ductal" (730/0). Kanser 
xiv 
payudara di peringkat III and VI adalah 60%. Faktor-faktor risiko kanser payudara 
adalah nullipara (nisbah ods (OR) 42.6, 950/0 julat kepercayaan (950/0 CI) 4.8-
380.8), mempunyai satu atau dua anak (OR 2.2, 950/0 CI 1.0-5.0), sejarah 
keluarga pengidap kanser payudara (OR 4.2, 950/0 Ct 1.4-12.8) dan pernah 
mengamal ubat perancang keluarga (OR 2.8, 95% CI 1.4-5.8). Pesakit kanser 
payudara mempunyai tahap pengetahuan yang lebih baik dengan perbezaan 
bererti berbanding dengan kawalan (ujian berpasang t =4.9, p<0.001). Tiada 
perbezaan bererti antara kes dan kawalan bagi jumlah markah sikap (ujian 
berpasang t =0.6, p>0.05) dan amalan (ujian berpasang t = -0.7, p>0.05). 
Kurang dari 200/0 kes dan kawalan mengamalkan pemeriksaan sendiri payudara 
bulanan. Kajian ini melibatkan pesakit kanser payudara yang lebih muda 
sebelum menopos. Pro-til kanser payudara dikajian ini berbeza daripada kajian 
lain seperti taburan umur dan etnik. Kajian ini mengesahkan faktor risiko yang 
sarna seperti kajian di barat bertanggungjawab kepada kejadian kanser 
payudara di Kelantan. la juga menyakong teari yang kanser payudara berkaitan 
dengan pendedahan kepada estrogen harmon dan faktar keturunan. la 
menekankan kepentingan untuk mempunyai anak terutama lebih daripada dua, 
amaran kepada wanita yang pernah menggunakan ubat perancang keluarga dan 
yang mempunyai sejarah keluarga kanser payudara. Tahap pengetahuan yang 
lebih baik tidak menjamin sikap positif dan amalan yang lebih baik. Pengajaran 
kesihatan diperfukan terutama untuk wanita berisiko tinggi supaya dapat 
menukar sikap mereka dan meningkatkan amalan pemeriksaan saringan yang 
berkala dan betul bagi kanser payudara. 
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ABSTRACT 
Breast cancer is the commonest female cancer in the world with Malaysian 
prevalence of 86.2 per 100,000 women in 1996. There was an increasing trend 
of breast cancer mortality rate in Malaysia from 0.61 in 1983 to 1.8 per 100,000 
populations in 1992. This study was aimed to identify profile, risk factors of breast 
cancer and to compare the level of knowledge, attitude and practice regarding 
breast cancer between cases and controls. A matched case-control study was 
carried out at hospitals in Kelantan. A standardized questionnaire was used to 
interview 147 histologically confirmed breast cancer patients and 147 controls. 
Controls were non-breast cancer patients who were matched for age and 
ethnicity of cases and non-malignant, non-gynaecologicaf, non-hormonal and 
non-endocrinological patients. Potential risk factors and score of knowledge, 
attitude and practice were initially analysed by simple conditional logistic 
regression and paired t test. Multiple conditional logistic regression modelling 
was later used to control potential confounding factors. The mean age of breast 
cancer patients was 46.3 :!: 9.3 years. The most common histological type was 
infiltrative ductal carcinoma (73%). Presentation at stage "' and VI was 60%. 
Factors contributing towards increased risk of breast cancer were nulliparity 
(Odds Ratio (OR) 42.6, 95% Confidence Interval (95% CI) 4.8-380.8), having one 
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or two children (OR 2.2, 95% CI 1.0-5.0), family history of breast cancer (OR 4.2, 
95% CI 1.4-12.8) and ever taken oral contraceptives (OC) (OR 2.8, 950/0 CI 1.4-
5.8). Cases had significantly better score of knowledge than controls (paired t 
test =4.9, p<O.001). There were no significant differences between cases and 
controls in total scores of attitude (paired t test =0.6, p>0.05) and practice (paired 
t test = -0.7, p>0.05). Less than 200/0 of cases and controls practised monthly 
Breast Self-Examination (8SE). This study included younger pre-menopausal 
women. The profile of breast cancers such as age and ethnic distributions was 
different from other studies. This study reconfirmed that similar risk factors 
identified in western population were responsible for the occurrence of breast 
cancer in Kelantan. It also supported the theory that breast cancer occurrence 
was related to oestrogen exposure and familial factors. It suggested the 
importance of having children especially more than two and caution for OC users 
and women with family history of breast cancer. Significant higher level of 
knowledge did not ensure positive attitude and better practice. Health education 
is needed especially for high-risk women in order to change their attitude and 
facilitate regular correct method of screening for breast cancer. 
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INTRODUCTION 
CHAPTER ONE 
INTRODUCTION 
Global trend suggests an epidemiological transition from the improvement of 
communicable diseases through immunization, environmental sanitation and 
socia-economic status of population, to the increasing trend of non-
communicable, degenerative and life-style related diseases (Linet, 2000). 
One of the degenerative, non-communicable and life-style diseases is cancer. 
Cancer is a public health problem in developing as well as developed countries. 
In developed countries, cancer was the second most common cause of death, 
while in developing countries it was responsible for about one in 20 deaths 
(Ministry of Health Malaysia, 1997a). It was expected that cancer incidence 
would increase by 250/0 in the developed and 1000/0 in the developing world in the 
next 25 years (Ministry of Health Malaysia, 1997a). 
Cancer was the fifth leading cause of death in government hospitals in 1996 
compared to 1978 where cancer was not even in the top ten of the list (Ministry 
of Health Malaysia, 1997a). The emergence of cancer as one of the ten leading 
causes of death in Malaysia warrants a serious consideration towards its 
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prevention and control. The incidence rate for all types of cancer in Malaysia was 
150 per 100 000 population in 1996, compared to 95.1 per 100 000 population in 
1978 (Ministry of Health Malaysia, 1997b). The prevalence rate of all types of 
cancer in males and females were 153.1 and 301.3, respectively, per 100 000 
population. Breast cancer was the commonest cancer among females (45.9 per 
100 000 population) in 1996, followed by cervical and stomach cancer (Ministry 
of Health Malaysia, 1997b). 
1.1 OVERVIEW OF BREAST CANCER 
Breast cancer results from an anomaly of uncontrolled growth and division of 
breast cells. The breast cancer cells will destroy normal nearby tissues by local 
invasion and may break away from the primary site and enter the bloodstream 
and lymphatic system, thus spreading to other organs such as bone, lung, liver 
and brain. The diagnosis of breast cancer can only be made by histological 
examination of breast tissue. The breast tissue may be obtained by fine needle 
aspiration biopsy, core needle biopsy, incisional or excisional biopsy or 
stereotactic image guidance of needle biopsy for unpalpable masses. 
Breast tissue is a tubuloalveolar gland that consists of ductal and lobular units. 
The development and growth of breast tissue is under the influence of oestrogen, 
progesterone, adrenal hormones, pituitary hormones, and trophic effects of 
insulin and thyroid hormone. 
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Oestrogen is the primary hormone responsible for rapid proliferation of breast 
cells during puberty and pregnancy; that signals changes during the menstrual 
cycle and maintains the female structure of the breast. During puberty, 
oestrogens cause arborisation of the ductal system while progesterones induce 
development of terminal ducts with the presence of growth hormone and insulin 
(Farrar et a/., 1995). During hormonal changes of menstrual cycle, the lobular 
units undergo histologic alteration. Similarly, the lobular units undergo marked 
proliferation and enlargement during pregnancy. Furthermore, there is loss of 
hormonal stimulation during post-menopause, hence a decrease in absolute 
number and diffuse atrophy of the residual lobular units (Kuhns and Ackermenn, 
1995). 
Besides being responsible for the growth of normal breast tissues, oestrogens 
also play important role in stimulating the growth of cancer cells of the breast. 
Oestrogens have direct effect on tumour cells by stimulating the release of 
mitogenic growth factors and facilitate the invasion and metastases of the tumour 
(Spratt at al" 1995, Clemons and Goss, 2001). 
Oestrogen and progesterone receptors status is important to determine in breast 
cancer. The positive receptors test means the breast cancer cells grow under the 
influence of hormone, thus predicts whether the cancer is sensitive to hormones. 
The treatment option is dependent upon the hormone receptor tests and staging 
of breast cancer. 
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Tumour, Nodal and Metastasis (TNM) classification for staging of breast cancer 
is based on clinical examination of the tumour (T), regional lymph nodes 
involvement (N) and distant metastases (M). It is introduced to predict prognOSiS, 
determine the choice of treatment and compare the results of different treatment 
approaches. Table 1.1 shows the TNM classification for the staging of breast 
cancer, while table 1.2 shows the grouping of theTNM staging of breast cancer. 
Table 1.1 TNM classification for staging of breast cancer* 
Primary Tumour 
Tx Primary tumour cannot be assessed. 
TO No evidence of primary tumour. 
T1 s Carcinoma-in-situ: intraductal carcinoma, lobular carcinoma, or Pagefs 
disease of nipple with no tumour. 
T1 Tumour $ 2 cm in greatest dimension. 
T1 a $ 0.5 em in greatest diameter. 
T1b > 0.5 em, but not> 1 em in greatest diameter. 
T1c > 1 cm, but not> 2 cm in greatest diameter. 
T2 Tumour> 2 em but not> 5 em in greatest dimension. 
T3 Tumour> 5 cm in greatest dimension. 
T 4 Tumour of any size with direct extension into chest wall or skin. 
T4a Extension to chest wall. 
T4b Edema (including peau d'orange) or skin ulceration or satellite skin nodules 
confined to same breast. 
T 4c Inflammatory carcinoma. 
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Table 1.1 Continued 
Regional Lymph Node Involvement 
Nx Regional Lymph node cannot be assessed. 
NO No regional lymph node involvement. 
N1 Metastasis to movable ipsilateral axillary lymph node{s). 
N1a Only micrometastasis (none larger than O.2cm). 
N1b Metastasis to lymph node(s), any larger than 0.2 em. 
N1bi Metastasis in 1 to 3 lymph nodes, any> O.2cm and all < 2 cm in 
greatest dimension. 
N1 bii Metastasis in 1 to 4 lymph nodes, any > O.2cm and all < 2 cm in 
greatest dimension. 
N1biii Extension of tumour beyond the capsule of a lymph node, any 
metastasis in 1 to 5 lymph nodes, > 0.2 em and all < 2 em in 
greatest dimension. 
N1 biv Metastasis to a lymph node ~ 2 em in greatest dimension . 
. 
N2 Metastasis to ipsilateral axillary lymph node(s) fixed to one another 
or to other structures. 
N3 Metastasis to ipsilateral internal mammary axillary lymph node( s). 
Distant Metastasis 
Mx 
MO 
M1 
* 8eahrs et a/., 1992. 
Presence of distant metastasis cannot be assessed. 
No distant metastasis. 
Distant metastasis present (including ipsilateral supraclavicular 
lymph nodes). 
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Table 1.2 TNM stage grouping* 
Stages 
Stage 0 
Stage I 
Stage itA 
Stage liB 
Stage iliA 
Stage 1118 
Stage IV 
*8eahrs et al., 1992. 
TNM classification 
TIS, NO, MO 
T1, NO, MO 
TO-1, N1, MO 
T2, NO, MO 
T2, N1, MO 
T3, NO, MO 
TO-2, N2, MO 
T3, N1-2, MO 
T4, N1-2, MO 
AnyT, N3, MO 
Any T, any N, M1 
1.2 PREVALENCE OF BREAST CANCER 
Breast cancer is an important public health problem and contributes toward 
significant morbidity and mortality among Malaysian women. It was the most 
common female cancer in the world (McPherson et a/., 2000) and in Malaysia 
(Ministry of Health Malaysia, 1997b) but the second commonest cancer after 
cervical cancer in Kelantan (Department of Health Kelantan, 1996). 
There were geographical and ethnic variations in breast cancer incidence rates. 
The highest rates were in North America and Europe and lowest in Asia and 
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Africa. The age-adjusted incidence of invasive breast cancer was highest among 
white, Hawaiian and black women, while the lowest rates were reported among 
Korean, .American Indian, and Vietnamese women (National Cancer Institute, 
1999). Surveillance Epidemiology End Result (SEER) Cancer Statistics Review 
1973-1997 reported that the incidence rate of breast cancer in USA in 1997 was 
115.4 and the mortality rate was 23.3 per 100 000 women (National Cancer 
Institute, 1999). Japanese, Chinese and Filipino women, who migrated to the 
USA, had elevated risk of breast cancer after several generations and their 
incidence rate of breast cancer was approaching the rate of American whites 
(National Cancer Institute, 1999). 
Breast cancer incidence rates in the USA had been 4-7 times higher than those 
reported in China or Japan (National Cancer Institute, 1999). The incidence rate 
of breast cancer in Malaysia was also very much lower compared to those in the 
west. The incidence rate of breast cancer in Peninsular Malaysia in 1982 was 28 
per 100 000 women compared to 69 per 100 000 women in the United States in 
the same year (Chan, 1982). Penang Cancer Registry (1999), the only reliable 
regional cancer registry in Malaysia reported that the incidence rate of breast 
cancer in 1996 was 23.8 per 100 000 women. The second National Health and 
Morbidity Survey showed that the breast cancer prevalence in Malaysia was 86.2 
per 100 000 women in 1996 (Ministry of Health Malaysia, 1997b). Chinese 
women had a higher incidence (34 per 100 000 women) compared to Malays (24 
per 100000 women) (Chan, 1982). 
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Breast cancer was the commonest malignancy among women that contributed 
10.7% of female cancer cases in University Hospital, Kuala Lumpur from 1972 to 
1974, 13% of Singaporean cancers from 1968 to 1970 and 13.8% of cancers 
diagnosed by the Institute of Medical Research, Kuala Lumpur from 1969 to 1971 
(Lim, 1982). Ganesan et a/. (1991) found that breast cancer contributed 180/0 of 
all female cancers in Sabah. Furthermore, McPherson et al. (2000) also reported 
that breast cancer contributed 18% of all female cancers in the world. 
The National Cancer Institute of the United States reported an overall decline in 
cancer incidence and mortality rates. The age-adjusted breast cancer mortality 
rate for white females in the USA dropped 6.80/0 between 1990 and 1995 (Chu et 
al., 1996). This was reverse from the earlier reports. The decline might be due to . 
the better cancer prevention and control efforts that included healthy life-style 
changes, educational efforts and regular cancer screening. Similarly, there were 
changes in the incidence and mortality rates of breast cancer in England and 
Wales since the introduction of screening programs, although other factors like 
better treatment may playa role (Quinn & Allen 1995). There was a reduction of 
up to 21 % in mortality rate from breast cancer from 1990 to 1998 in the United 
Kingdom (Blanks at a/., 2000). Furthermore, SEER program of the USA also 
noted that there were increasing incidence rates of stage I and II breast cancer, 
while stage III and IV breast cancer incidence rates were decreasing (National 
Cancer Institute, 1999). 
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In contrast, the trends in incidence and mortality rates of breast cancer in 
Malaysia were increasing. The under-reported mortality rate from breast cancer 
increased from 0.61 in 1983 to 1.8 per 100 000 women in 1992 (Kementerian 
Kesihatan Malaysia, 1994). The age-adjusted mortality rate of Peninsula 
Malaysia showed an increase from 3.7 in 1982 to 5.8 per 100 000 women in 
1990 (Yip and Ng, 1996). Data from population-based Singapore Cancer 
Registry between 1968 and 1992 revealed an average increase in the incidence 
rate of 3.60/0 over the 25 year period; 20.2 per 100 000 women between 1968 
and 1972 to 38.8 per 100 000 women between 1988 and 1992. It was projected 
that the rates would reach 55 per 100 000 women by 1995 (Seow et a/" 1996). 
1.3 RISK FACTORS OF FEMALE BREAST CANCER 
It is important to identify women at high-risk of breast cancer, in order to improve 
understanding of factors associated with breast cancer. This information is 
important for preventive and diagnostic purposes. It may also explain the low 
incidence rates in Asian women and the upward trend in the incidence in 
developing countries. 
Table 1.3 summarises the risk factors of female breast cancer (Kelsey, 1993). 
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Table 1.3 Summary of risk factors of female breast cancer* 
Factors 
Established risk factors 
(relative risk more than 4.0) 
Age 
Family history of breast cancer 
Established risk factors 
(relative risk 2.1 - 4.0) 
History of cancer in one breast 
Previous biopsy of benign proliferative 
Radiation to chest 
Established risk factors 
(relative risk 1.1 - 2.0) 
Socio-economic status 
Marital status 
Place of residence 
Ethnic group 
Bilateral oophorectomy before 40 years old 
Nulliparity 
Age at first full term pregnancy 
Age at menarche 
Age at menopause 
Obesity 
Uncertain risk factors 
Parity 
Breastfeeding 
Long term exposure to oral contraceptive (OC) 
Long term exposure to hormone replacement (HRn 
Height 
Alcohol consumption 
Cigarette smoking 
* Adapted from Kelsey I 1993 
¥Chan (1982), Yip and Ng (1996) 
High risk group 
Old 
Higher if having mother or 
sister with breast cancer 
Yes 
Yes 
Yes 
High 
Never married 
Urban 
Chinese Malaysian¥ 
No 
Yes 
After 30 years of age 
At 11 or younger 
After 55 years of age 
For post-menopausal 
High 
Never 
Yes 
Yes 
Tall 
Yes 
Yes 
The risk factors of breast cancer in Western populations had been extensively 
investigated and suggested that life-style and reproductive factors were strongly 
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related to breast cancer. In contrast, less information exists regarding factors that 
are associated with breast cancer in Asian women. A study by Ng et al. (1997) 
suggested that the same risk factors responsible for the higher incidence of 
breast cancer in western population, might explain the rise of breast cancer 
incidence in Singapore. 
A positive family history of breast cancer is among the most significant predictors 
of breast cancer risk (Pharoah et al., 1997, Fioretti et al., 1998, Tavani et al., 
1999, McPherson et al., 2000). Details of the family history are important, such 
as the relation of family members to patients, the age at which breast cancer is 
diagnosed, whether they are at pre- or post-menopausal or if one or both breasts 
are involved. The combination of multiple primary relatives, multiple generations, 
multiple occurrences of bilateral breast cancer or the occurrence during pre-
menopausal period suggests a genetic predisposition. Autosomal dominant 
genes BRCA-1 and BRCA-2 are related to the breast cancer occurrence (Tavani 
et al., 1999). 
Breast cancer has been shown to be associated with oestrogen exposure 
(Bernstein and Ross, 1993, Stephans, 1997). Oestrogen is responsible for the 
growth and proliferation of breast tissues. It is also responsible for the initiation of 
breast cancer cells (Clemons and Goss, 2001). Further evidence of the effect of 
oestrogen is from the effect of tamoxifen, an anti-oestrogen chemotherapeutic 
agent, in the reduction of breast cancer risk. However, Wiseman (2000) argued 
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that oestrogen is not the sale cause of breast cancer but only acting as a 
promoter of carcinogenesis since not many pregnant women have breast cancer 
and men also get breast cancer too. It is suggested that breast cancer has a 
single, unknown aetiology and not due to multiple causes. 
Increased or prolonged exposure to oestrogen is associated with a higher risk of 
developing breast cancer. Reproductive factors that increase the number of 
menstrual cycle such as early menarche, nulliparity, late onset of menopause 
and late age of having the first child, contribute toward higher risk of breast 
cancer (Helmrich et a/., 1983, Kelsey et a/., 1993, Stephans, 1997, Garland et a/., 
1998, Tavani et al., 1999, McPherson et a/., 2000). On the other hand, factors 
that reduce the number of ovulatory cycles are associated with lower risk of 
breast cancer such as moderate exercise, longer lactation and higher parity. 
Women who give birth to their first child before 30 years of age are at lower risk 
of developing breast cancer compared to those give birth for the first time after 
age 30 or those who never bear children. Women who underwent oophorectomy 
before the age of 35 years and did not take replacement oestrogen have a 
reduction in their breast cancer risk (Parazzini et al., 1997). Even hysterectomy 
alone is protective against breast cancer because it modifies ovulation through 
ovarian blood flow (Parazzini et al., 1997). Women who have had irregular 
menstrual cycles are prone toward anovulatory cycles, thus having lower risks for 
breast cancer (Garland et a/., 1998). Furthermore, having an abortion is related 
to a higher risk of breast cancer, regardless of whether it is spontaneous or 
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induced, due to the interruption of pregnancy (Melbye et al., 1998 Tavani et al., 
1999, Fioretti et al., 2000). Having an abortion also resulted in an incomplete 
differentiation of mammary gland cells making the tissue more susceptible to 
carcinogenesis (Kelsey et al., 1993). 
There is an inverse relation between breastfeeding and breast cancer risk 
regardless of duration (Furberg et a/., 1999). It was postulated that lactation 
reduced the woman's exposure to ovarian hormones by suppressing ovulation. 
There is reduced oestrogen production during lactation and changes in epithelial 
cells of mammary ductules during lactation. Furthermore, breastfeeding may 
remove oestrogen or carcinogens through breast milk and delay reestablishment 
of ovulation. On the other hand, many Western studies found no protective effect 
of breastfeeding on breast cancer (Kelsey et a/., 1993, Michels et al., 1996). The 
failure to detect the association was due to the low prevalence of prolonged 
breastfeeding in western population (Lipworth et al., 2000). 
Exogenous oestrogen such as those obtained through hormone replacement 
therapy (HRT) and oral contraceptives (OC) also has roles in the development of 
breast cancer. 
Use of OC is weakly associated with breast cancer (Collaborative Group on 
Hormonal Factors in Breast Cancer, 1996, Tavani et al., 1999, McPherson et ai, 
2000). Collaborative analysis of data from 54 epidemiologic studies of breast 
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cancer in 25 countries showed only small increase in the risk of breast cancer for 
the current or previous users of combined OC (Collaborative Group on Hormonal 
Factors in Breast Cancer, 1996). The association of OC with breast cancer were 
related to the duration, dosage, pattern of usage, type of OC and the age of first 
using it. On the other hand, a meta-analysis study showed no increased risk for 
ever users of OC even for long duration (Romieu et a/., 1990). 
All types of study designs showed an association of ever users of HRT with 
breast cancer occurrence (McPherson et a/., 2000, Clemons and Goss, 2001). It 
was closely related to the duration of intake, type and dosage of preparation 
used. The risks associated with continuous combined HRT were tended to be 
substantially less than those associated with sequential combined regime. The 
risks associated with combined HRT were higher than that in oestrogen 
replacement alone (Ross et a/., 2000). Progestogens did not protect breast from 
carcinogenic effect of oestrogen but increased the oestrogen-related risk of 
breast cancer. It was reported that even one year of HRT could increase the 
chances of breast cancer by 2.3% for each additional year (Collaborative Group 
on Hormonal Factors in Breast Cancer, 1997). The effect however, would 
disappear after 5 years of cessation of intake. 
Obese, post-menopausal women are at high risk of developing breast cancer 
(Helmrich et a/., 1983, Haybittle et a/., 1996, Tavani et a/., 1999, Lam et a/., 
2000). It is related to the hormonal influences of obesity. The increased body fat 
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stores can lead to higher circulating levels of oestrogen with peripheral 
conversion of lipocytes, hence promoting the growth of breast cancer cells 
(Hirose et al., 1999, Clemons and Goss, 2000). Obesity is also associated with 
advanced stage of breast cancer at initial diagnosis. On the other hand, there is 
an inverse relationship between body mass index (8MI) and pre-menopausal 
breast cancer (Trentham-Dietz et al., 1997, Hirose et al., 1999). The proposed 
mechanism is that obese, pre-menopausal women tend to have longer menstrual 
cycles and greater tenden(.ies for anovulatory cycles, thus lowering the net 
oestrogen influence on the target breast cells. Before menopause, the excess fat 
has little influence on the level of oestrogen due to the overriding influence of 
ovarian oestrogen production. The timing of gaining weight during adulthood, 
especially after menopause, is also critical in determining the association 
between weight changes and breast cancer (Ng et al., 1997). Women who gain 
weight throughout adulthood are at an increased risk for developing breast 
cancer after menopause (McTiernan, 2000). Ng et aJ. (1997) also found that 
central obesity was more relevant in increasing the risk of breast cancer. 
While it has been clearly established that smoking increases the risk of 
developing lung cancer, it is suggested that smoking may contribute towards 
increased risk of breast cancer as well. Tobacco smoke is thought to interfere 
with oestrogen metabolism and a carcinogen itself. Timing of exposure and 
duration of smoking are related to the breast cancer risk. Smoking increased the 
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risk of developing breast cancer for women who had smoked for more than 30 
years (Bennicke et al., 1995). 
Dietary factors have been linked to breast cancer development. It is noted that 
breast cancer is less common in countries where the typical diet is low in total fat 
especially polysaturated fat (Yuan et al., 1995). Cross cultural studies 
demonstrated that women from low risk countries like Asia and Africa acquired 
the same high risk of breast cancer as their American counterpart when they 
migrated to the US and adopted western diet (Yuan et al., 1995). A study on the 
effect of diet on breast cancer in Singapore suggested that soya products 
containing phyto-oestrogen, which suppresses endogenous oestrogenic activity 
of breast cells, were responsible for the low rates of breast cancer in Asian 
countries (Lee et al., 1991). Consuming less saturated animal fat may reduce the 
risks of breast cancer as well as other diseases. Meanwhile, Knekt et al. (1990), 
in a longitudinal study, found that there was no significant association between 
absolute fat intake and the occurrence of breast cancer. Meta-analysis of 23 
studies on dietary fat association with breast cancer had shown that only case-
control studies showed significant associations while cohort studies did not (Boyd 
etal., 1993). 
Vitamin C, E and beta-carotene have anti-oxidant properties while vitamin A is a 
regulator of cellular differentiation that may reduce the risk of breast cancer. A 
study by Hunter et al. (1993) showed that large intakes of vitamin C and E did not 
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protect women from breast cancer and low intake of vitamin A may increase the 
risk of breast cancer. Another study found that vitamin E, dietary fibre and 
supplements did not significantly related with breast cancer (Verhoeven et a/., 
1997). Furthermore, there were significant inverse relationships between the risk 
of breast cancer and carotenoids and vitamin A from foods but not supplement of 
vitamin A, C or E (Zhang et al., 1999). A case-control study in Greece found that 
only beta-carotene was inversely associated with breast cancer in pre-
menopausal women whereas other micronutrients were not significantly related 
(Bohlke et a/., 1999). High intake of dietary fibres, especially vegetables, fruits 
and whole grains, was significantly reduced the risk of breast cancer (Yuan et a/., 
1995). 
In addition to other general health benefits, exercise may alter body's hormonal 
environment thereby possibly reducing the risk of breast cancer. Women who 
exercised at least 4 hours per week had a 370/0 reduction in the risk of breast 
cancer (Thune et al., 1997). Exercise is associated with increased frequency of 
anovulatory cycles or if the ovulation does occur, the levels of serum oestrogen 
and serum progesterone in the cycles are much decreased (Fioretti et al., 1998). 
Intensive exercise can cause amenorrhoea. The benefits were greatest among 
women who had borne children and were physically active in their teens and 
early twenties. The effect of physical activity is also related closely to the BMI of 
the women. Excessive BMI was related to higher risk of breast cancer in post-
menopausal women (Tavani et al., 1999). 
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There was an association between benign breast diseases and breast cancer. 
Women, who have had breast biopsies for any reason, had higher risks of 
developing subsequent breast cancer. A study by Jacobs et al. (1999) found that 
radial scars present in benign breast biopsies were significantly associated with 
increased risks of subsequent breast cancer. An overall incidence of breast 
cancer in patients with palpable cysts was 2.81 times greater than that of the 
general population (Dixon et a/., 1999). It was suggested that the occurrence of a 
cyst is a marker of epidermal activity that has a higher concentration of 
oestrogen, thus related with an increased risk of breast cancer. 
1.4 BREAST CANCER SCREENING 
Only half of women with breast cancer have identifiable risk factors (Linet, 2000). 
Some of the breast cancer risk factors are not readily modifiable through either 
behavioural or environmental changes. The extent of prevention of breast cancer 
achieved by healthy lifestyles, such as dietary control and exercise, is not known. 
Thus, secondary prevention of early detection and prompt treatment, with the 
goal of reducing breast cancer mortality, should be targeted in order to halt the 
increasing trend of breast cancer among Malaysian women. 
The National Program of Breast Cancer Prevention was launched by Ministry of 
Health in 1995 as part of its Healthy Life-Style Campaign. It has a broad risk 
18 
target group and is mainly an opportunistic screening tied to the Family Health 
Development Program of the Ministry of Health. Educational BSE (Breast-self 
Examination) is taught mainly during antenatal visits at health centres, which is 
not frequent. Furthermore, CBE (Clinical Breast Examination)· is done during 
family planning program and whenever is indicated or requested. Mammography, 
which is expensive and requires well-trained staff, is not used at all as a 
screening tool in Malaysia. Mammography cannot be considered as an ideal 
screening method since it is technically complex, relatively expensive and has 
poor accessibility and availability in Malaysia. Besides not cost-effective, 
mammography has limited usefulness in women under the age of 40 years 
(Overmoyer, 1999). Thus, SSE and CBE are the obvious choices as screening 
methods for breast cancer. 
Effective breast cancer screening detects disease during the pre-clinical phase 
before the development of symptoms and thereby has a favourable impact on the 
mortality rate (Overmoyer, 1999). Screening programs should be aimed at 
reducing mortality as well as the incidence of breast cancer, and targeted at high-
risk women. Only mammogram has been shown to be capable of reducing breast 
cancer mortality (Chu et al., 1996). 
The benefit of SSE is somewhat controverSial. Monthly SSE is safe, easy and 
potentially beneficial because of its non-invasive method of detection. SSE 
provides an opportunity to detect breast problem early, thus facilitating 
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consultation and early management. Besides that, early stage detection of a 
disease is associated with better treatment options and less morbidity compared 
with those presenting at an advanced stage. With adequate education and 
training, women can be expected to be able to care for their own breasts. 
Although it is the least sensitive method of breast cancer screening (sensitivity 
ranging 12-25%) (Fletcher et al., 1993) and has a high false positive rate, BSE 
has the potential in detecting smaller tumours with better histological grade and 
lesser lymph node involvement (Locker et a/., 1989). 
Most studies indicated a positive association between the practice of BSE and 
CBE and early detection of breast cancer. A meta-analysis reported that those 
who had SSE at least once before their illness had lesser lymph node 
involvement and smaller tumour diameter compared to those who did not 
practised (Hill et al" 1988). Studies have shown that early stage of detection is 
associated with better survival rates. A study of pT1 NOMO breast cancer found 
the 10-year and 20-year survival rates, corrected for intercurrent deaths, were 
93%) and 81 % respectively (Joensuu et a/., 1999). Breast cancer commonly 
presented late in Malaysia. Information from the Ministry of Health, Malaysia 
revealed that only 5.8% presented in stage I where the disease is confined to the 
breast only, 66.7% presented in stage II and III where the disease has extended 
to lymph nodes and 27% presented in stage IV with distant metastasis (Ministry 
of Health Malaysia, 1994). Based on this information, there is good evidence to 
encourage women to practise SSE regularly. 
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The efficacy of BSE in reducing breast cancer mortality has conflicting results. A 
randomised trial of 267,040 women in Shanghai showed no significant difference 
in breast cancer mortality between those who were given intensive training in 
BSE compared to controls after 5 years follow-up (Thomas et al., 1997). 
However, a non-randomised study in UK showed a reduction in breast cancer 
mortality resulting from screening and education about BSE after 16 years of 
intervention (UK Trial of Early Detection of Breast Cancer Group, 1999). 
SSE can detect changes and differences rather than in the interpretation of self-
examination findings. By doing monthly BSE, women will become familiar with 
the normal appearance, configuration and texture of their breasts and may be 
able to identify any changes. BSE is a preventive strategy that could be 
applicable and acceptable to all women regardless of their current biological life 
phases, reproductive desires, hormonal needs, cultural and financial constraints 
and risk levels. 
There are various methods of doing SSE. The Health Education Unit of Ministry 
of Health, Malaysia has produced a standardized guideline for BSE, in order to 
gain maximum benefit from practising it (Appendix 2). 
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1.5 KNOWLEDGE, ATTITUDE AND BELIEFS 
Health screening behaviour is closely related to the individual's knowledge, 
attitude and beliefs. Although better knowledge on breast cancer does not 
necessarily translate into actual practice of SSE, women who have better 
knowledge are more likely to practice it. The second National Health and 
Morbidity Survey found that those who practised screening methods of breast 
cancer were those who had higher educational level that in turn influenced their 
knowledge and awareness on breast cancer (Ministry of Health Malaysia, 
1997b). It is very important to understand the extent of people's knowledge, 
attitude and beliefs in relation to breast cancer in order to develop an effective 
intervention and prevention programs on breast cancer. Lack of regular cancer 
screening practice, which is related to poor knowledge and negative attitude, has 
been blamed to the late presentation of breast cancer at advanced stages. 
Poor knowledge regarding breast cancer and its screening methods may be due 
to the unavailability of information in the absence of regular educational 
campaign. Some women may be unaware of the need for BSE. Women who 
have specific breast complaints may not know where to go. 
Cultural values with respect to modesty and sexuality partly account for the lack 
of attention to breast health. Some women are not comfortable when talking 
about breasts or sexuality. Many may feel that breast examination is an intimate 
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examination. Some may feel upset or surprised if their physicians requested to 
examine their breasts. Many women prefer female physicians when examining 
their breasts and may actually postpone or delay consultation out of 
embarrassment. 
The women's knowledge, attitude and beliefs regarding breast cancer are closely 
related to previous life experiences with illnesses and medical systems, religious 
beliefs, socia-economic factors and the impact mass media and healthy life-style 
campaigns mounted by the Ministry of Health. 
1.6 CONCEPTUAL FRAMEWORK 
The conceptual framework of this study is shown as figure 1.1. It was postulated 
that oestrogen and genetic play important roles in the occurrence of breast 
cancer (Martin and Weber, 2000). Oestrogens are produced endogenously by 
ovaries and adrenals. Conversion of androgen to oestrogens may occur in fatty 
tissues especially in post-menopausal period when ovaries had regressed. 
Factors as mentioned before such as nulliparity, having first full-term birth after 
the age of 30 years, early menarche, late menopause, never breastfeeding and 
obesity may relatively increased or prolonged the women's exposure to 
oestrogens, thus increased risk of developing breast cancer. While exogenous 
oestrogens from OCP and HRT are also related to higher risk of developing 
breast cancer. 
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Family history of breast cancer is associated with the occurrence of breast 
cancer. Women who have genes called BRCA 1 and BRCA 2 are at risk of 
breast cancer. Besides hormonal and genetic factors, there are other factors that 
may contribute towards higher risk of breast cancer. Some benign breast 
diseases have higher risk to develop or progress to breast cancer. Taking high 
animal fat diet, radiation, alcohol intake and smoking may also contribute to the 
higher risk of breast cancer. 
Breast cancer should be detected at earlier stages via screening methods of 
breast cancer: mammography. CBE and BSE. The practice of screening 
methods is related to high level of knowledge and positive attitude and beliefs 
about breast cancer. High level of knowledge and positive attitude and beliefs are 
also needed in order for women to have appropriate successful management and 
thus longer survival. 
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